DK350876A - Ekstrakter af det hemopoietiske system - Google Patents

Ekstrakter af det hemopoietiske system

Info

Publication number
DK350876A
DK350876A DK350876A DK350876A DK350876A DK 350876 A DK350876 A DK 350876A DK 350876 A DK350876 A DK 350876A DK 350876 A DK350876 A DK 350876A DK 350876 A DK350876 A DK 350876A
Authority
DK
Denmark
Prior art keywords
extracts
hemopoietic system
hemopoietic
Prior art date
Application number
DK350876A
Other languages
English (en)
Inventor
W A Jones
T L S T H Yuen
T Rytomaa
N J Harper
H F Frost
Original Assignee
Union International Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union International Co Ltd filed Critical Union International Co Ltd
Publication of DK350876A publication Critical patent/DK350876A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK350876A 1975-08-05 1976-08-04 Ekstrakter af det hemopoietiske system DK350876A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32659/75A GB1579120A (en) 1975-08-05 1975-08-05 Extracts of the haemopoietic system

Publications (1)

Publication Number Publication Date
DK350876A true DK350876A (da) 1977-02-06

Family

ID=10342062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK350876A DK350876A (da) 1975-08-05 1976-08-04 Ekstrakter af det hemopoietiske system

Country Status (19)

Country Link
US (1) US4294824A (da)
JP (1) JPS5218807A (da)
AR (1) AR211931A1 (da)
AU (1) AU515950B2 (da)
BE (1) BE844875A (da)
CA (1) CA1063019A (da)
DE (1) DE2635065C2 (da)
DK (1) DK350876A (da)
FI (1) FI762178A7 (da)
FR (1) FR2320106A1 (da)
GB (1) GB1579120A (da)
IE (1) IE44378B1 (da)
IN (1) IN144537B (da)
IT (1) IT1062655B (da)
LU (1) LU75535A1 (da)
NL (1) NL7608651A (da)
NZ (1) NZ181653A (da)
SE (1) SE7608771L (da)
ZA (1) ZA764643B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
JPS6339609Y2 (da) * 1980-11-21 1988-10-18
JPS59141520A (ja) * 1983-02-02 1984-08-14 Kyowa Hakko Kogyo Co Ltd Ｄｎａ合成抑制物質
CA2129436A1 (en) * 1992-12-04 1994-06-05 Satoko Yamada Hematopoietic inhibiting factor containing compositions
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
ATE268810T1 (de) * 1995-12-21 2004-06-15 Genzyme Corp Methode zur zellyse
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
HU228495B1 (en) 1998-03-26 2013-03-28 Swedish Orphan Blovltrum Internat Ab Process for continuous purification and concentration of leukocytes from blood
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6664049B1 (en) * 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
DE102004047262A1 (de) * 2004-09-24 2006-04-06 Ipss International Pharmaceutical Strategies & Solutions Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen
EP1640012A1 (de) * 2004-09-24 2006-03-29 Salama, Zoser B. nat.rer.Dr. Pharmazeutisches Mittel enthaltend Blutbestandteile 10 kDa und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems
US20060067942A1 (en) * 2004-09-24 2006-03-30 Salama Zoser B Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals
RU2278675C1 (ru) * 2005-01-17 2006-06-27 Юрий Борисович Иванов Антимикробное средство и фармацевтическая композиция, содержащая эффективное количество антимикробного средства
RU2304978C2 (ru) * 2005-07-14 2007-08-27 Георгий Михайлович Элбакидзе Средство тканеспецифического регулирования митохондриальных процессов и его применение при лечении заболеваний (варианты)

Also Published As

Publication number Publication date
IN144537B (da) 1978-05-13
BE844875A (fr) 1977-02-04
NL7608651A (nl) 1977-02-08
CA1063019A (en) 1979-09-25
AU515950B2 (en) 1981-05-14
FI762178A7 (da) 1977-02-06
ZA764643B (en) 1978-03-29
NZ181653A (en) 1979-01-11
DE2635065A1 (de) 1977-02-17
FR2320106A1 (fr) 1977-03-04
LU75535A1 (da) 1978-02-13
US4294824A (en) 1981-10-13
DE2635065C2 (de) 1983-10-27
FR2320106B1 (da) 1980-11-07
IE44378L (en) 1977-02-05
AU1661476A (en) 1978-02-09
SE7608771L (sv) 1977-02-06
GB1579120A (en) 1980-11-12
IT1062655B (it) 1984-10-20
IE44378B1 (en) 1981-11-04
JPS5218807A (en) 1977-02-12
AR211931A1 (es) 1978-04-14

Similar Documents

Publication Publication Date Title
SE415436B (sv) Televisionssystem
SE7611217L (sv) Telekonferenssystem
DK320977A (da) Fremgangsmade til fremstilling af bindemidler til elektrodyppelakering
LU88282I2 (fr) Anandron
BR7601529A (pt) Chuveiro aperfeicoado
DK321177A (da) Fremgangsmade til fremstilling af bindemidler til elektrodyppelakering
FR2300037A1 (fr) System
DK550576A (da) Fremgangsmade til fremstilling af argininderivater
FR2300190A1 (fr) Element de parement
FR2328154A1 (fr) Raccord de reduction
FR2320106A1 (fr) Extraits du systeme hemopoietique
DK457576A (da) Fremgangsmade til fremstilling af antibakterielle midler
AT335804B (de) Fitting
SE7611414L (sv) Prostaglandinderivat
DK385276A (da) Flangeforbindelse
FI772463A7 (fi) Anvaendning av det magnettekniska systemet
SE385533B (sv) Tvaapparatsystem
DK318876A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK517176A (da) Fremstilling af ethylchlorthioformiat
DK435776A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK435876A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK66176A (da) Fremgangsmade til fremstilling af substituerede imidazoler
SE7607033L (sv) Duschkar
FR2338264A1 (fr) Hydantoines
FR2308685A1 (fr) Desucrage de la melasse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment